Request for Covid-19 Impact Assessment of this Report
The United States Lacosamide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lacosamide market, reaching US$ million by the year 2028. As for the Europe Lacosamide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lacosamide players cover UCB, Teva, Amneal Pharmaceuticals, and MSN Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral tablets
Oral solution
Intravenous
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adults
Pediatric patients
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
UCB
Teva
Amneal Pharmaceuticals
MSN Laboratories
Alembic Pharma
Glenmark
Aurobindo Pharma
Accord Healthcare
Mylan
Sun Pharma
Apotex
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lacosamide Market Size 2017-2028
2.1.2 Lacosamide Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Lacosamide Segment by Type
2.2.1 Oral tablets
2.2.2 Oral solution
2.2.3 Intravenous
2.3 Lacosamide Market Size by Type
2.3.1 Lacosamide Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Lacosamide Market Size Market Share by Type (2017-2022)
2.4 Lacosamide Segment by Application
2.4.1 Adults
2.4.2 Pediatric patients
2.5 Lacosamide Market Size by Application
2.5.1 Lacosamide Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Lacosamide Market Size Market Share by Application (2017-2022)
3 Lacosamide Market Size by Player
3.1 Lacosamide Market Size Market Share by Players
3.1.1 Global Lacosamide Revenue by Players (2020-2022)
3.1.2 Global Lacosamide Revenue Market Share by Players (2020-2022)
3.2 Global Lacosamide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lacosamide by Regions
4.1 Lacosamide Market Size by Regions (2017-2022)
4.2 Americas Lacosamide Market Size Growth (2017-2022)
4.3 APAC Lacosamide Market Size Growth (2017-2022)
4.4 Europe Lacosamide Market Size Growth (2017-2022)
4.5 Middle East & Africa Lacosamide Market Size Growth (2017-2022)
5 Americas
5.1 Americas Lacosamide Market Size by Country (2017-2022)
5.2 Americas Lacosamide Market Size by Type (2017-2022)
5.3 Americas Lacosamide Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Market Size by Region (2017-2022)
6.2 APAC Lacosamide Market Size by Type (2017-2022)
6.3 APAC Lacosamide Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lacosamide by Country (2017-2022)
7.2 Europe Lacosamide Market Size by Type (2017-2022)
7.3 Europe Lacosamide Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lacosamide by Region (2017-2022)
8.2 Middle East & Africa Lacosamide Market Size by Type (2017-2022)
8.3 Middle East & Africa Lacosamide Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lacosamide Market Forecast
10.1 Global Lacosamide Forecast by Regions (2023-2028)
10.1.1 Global Lacosamide Forecast by Regions (2023-2028)
10.1.2 Americas Lacosamide Forecast
10.1.3 APAC Lacosamide Forecast
10.1.4 Europe Lacosamide Forecast
10.1.5 Middle East & Africa Lacosamide Forecast
10.2 Americas Lacosamide Forecast by Country (2023-2028)
10.2.1 United States Lacosamide Market Forecast
10.2.2 Canada Lacosamide Market Forecast
10.2.3 Mexico Lacosamide Market Forecast
10.2.4 Brazil Lacosamide Market Forecast
10.3 APAC Lacosamide Forecast by Region (2023-2028)
10.3.1 China Lacosamide Market Forecast
10.3.2 Japan Lacosamide Market Forecast
10.3.3 Korea Lacosamide Market Forecast
10.3.4 Southeast Asia Lacosamide Market Forecast
10.3.5 India Lacosamide Market Forecast
10.3.6 Australia Lacosamide Market Forecast
10.4 Europe Lacosamide Forecast by Country (2023-2028)
10.4.1 Germany Lacosamide Market Forecast
10.4.2 France Lacosamide Market Forecast
10.4.3 UK Lacosamide Market Forecast
10.4.4 Italy Lacosamide Market Forecast
10.4.5 Russia Lacosamide Market Forecast
10.5 Middle East & Africa Lacosamide Forecast by Region (2023-2028)
10.5.1 Egypt Lacosamide Market Forecast
10.5.2 South Africa Lacosamide Market Forecast
10.5.3 Israel Lacosamide Market Forecast
10.5.4 Turkey Lacosamide Market Forecast
10.5.5 GCC Countries Lacosamide Market Forecast
10.6 Global Lacosamide Forecast by Type (2023-2028)
10.7 Global Lacosamide Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 UCB
11.1.1 UCB Company Information
11.1.2 UCB Lacosamide Product Offered
11.1.3 UCB Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 UCB Main Business Overview
11.1.5 UCB Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Lacosamide Product Offered
11.2.3 Teva Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Company Information
11.3.2 Amneal Pharmaceuticals Lacosamide Product Offered
11.3.3 Amneal Pharmaceuticals Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Amneal Pharmaceuticals Main Business Overview
11.3.5 Amneal Pharmaceuticals Latest Developments
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Information
11.4.2 MSN Laboratories Lacosamide Product Offered
11.4.3 MSN Laboratories Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 MSN Laboratories Main Business Overview
11.4.5 MSN Laboratories Latest Developments
11.5 Alembic Pharma
11.5.1 Alembic Pharma Company Information
11.5.2 Alembic Pharma Lacosamide Product Offered
11.5.3 Alembic Pharma Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Alembic Pharma Main Business Overview
11.5.5 Alembic Pharma Latest Developments
11.6 Glenmark
11.6.1 Glenmark Company Information
11.6.2 Glenmark Lacosamide Product Offered
11.6.3 Glenmark Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Glenmark Main Business Overview
11.6.5 Glenmark Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Lacosamide Product Offered
11.7.3 Aurobindo Pharma Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 Accord Healthcare
11.8.1 Accord Healthcare Company Information
11.8.2 Accord Healthcare Lacosamide Product Offered
11.8.3 Accord Healthcare Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Accord Healthcare Main Business Overview
11.8.5 Accord Healthcare Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Lacosamide Product Offered
11.9.3 Mylan Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Information
11.10.2 Sun Pharma Lacosamide Product Offered
11.10.3 Sun Pharma Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sun Pharma Main Business Overview
11.10.5 Sun Pharma Latest Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Lacosamide Product Offered
11.11.3 Apotex Lacosamide Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Apotex Main Business Overview
11.11.5 Apotex Latest Developments
12 Research Findings and Conclusion
Table 1. Lacosamide Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral tablets
Table 3. Major Players of Oral solution
Table 4. Major Players of Intravenous
Table 5. Lacosamide Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Lacosamide Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Lacosamide Market Size Market Share by Type (2017-2022)
Table 8. Lacosamide Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Lacosamide Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Lacosamide Market Size Market Share by Application (2017-2022)
Table 11. Global Lacosamide Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Lacosamide Revenue Market Share by Player (2020-2022)
Table 13. Lacosamide Key Players Head office and Products Offered
Table 14. Lacosamide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Lacosamide Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Lacosamide Market Size Market Share by Regions (2017-2022)
Table 19. Americas Lacosamide Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Lacosamide Market Size Market Share by Country (2017-2022)
Table 21. Americas Lacosamide Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Lacosamide Market Size Market Share by Type (2017-2022)
Table 23. Americas Lacosamide Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Lacosamide Market Size Market Share by Application (2017-2022)
Table 25. APAC Lacosamide Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Lacosamide Market Size Market Share by Region (2017-2022)
Table 27. APAC Lacosamide Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Lacosamide Market Size Market Share by Type (2017-2022)
Table 29. APAC Lacosamide Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Lacosamide Market Size Market Share by Application (2017-2022)
Table 31. Europe Lacosamide Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Lacosamide Market Size Market Share by Country (2017-2022)
Table 33. Europe Lacosamide Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Lacosamide Market Size Market Share by Type (2017-2022)
Table 35. Europe Lacosamide Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Lacosamide Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Lacosamide Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Lacosamide Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Lacosamide Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Lacosamide Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Lacosamide Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Lacosamide Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Lacosamide
Table 44. Key Market Challenges & Risks of Lacosamide
Table 45. Key Industry Trends of Lacosamide
Table 46. Global Lacosamide Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Lacosamide Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Lacosamide Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Lacosamide Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Lacosamide Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Lacosamide Market Size Market Share Forecast by Application (2023-2028)
Table 52. UCB Details, Company Type, Lacosamide Area Served and Its Competitors
Table 53. UCB Lacosamide Product Offered
Table 54. UCB Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. UCB Main Business
Table 56. UCB Latest Developments
Table 57. Teva Details, Company Type, Lacosamide Area Served and Its Competitors
Table 58. Teva Lacosamide Product Offered
Table 59. Teva Main Business
Table 60. Teva Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Teva Latest Developments
Table 62. Amneal Pharmaceuticals Details, Company Type, Lacosamide Area Served and Its Competitors
Table 63. Amneal Pharmaceuticals Lacosamide Product Offered
Table 64. Amneal Pharmaceuticals Main Business
Table 65. Amneal Pharmaceuticals Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Amneal Pharmaceuticals Latest Developments
Table 67. MSN Laboratories Details, Company Type, Lacosamide Area Served and Its Competitors
Table 68. MSN Laboratories Lacosamide Product Offered
Table 69. MSN Laboratories Main Business
Table 70. MSN Laboratories Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. MSN Laboratories Latest Developments
Table 72. Alembic Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 73. Alembic Pharma Lacosamide Product Offered
Table 74. Alembic Pharma Main Business
Table 75. Alembic Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Alembic Pharma Latest Developments
Table 77. Glenmark Details, Company Type, Lacosamide Area Served and Its Competitors
Table 78. Glenmark Lacosamide Product Offered
Table 79. Glenmark Main Business
Table 80. Glenmark Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Glenmark Latest Developments
Table 82. Aurobindo Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 83. Aurobindo Pharma Lacosamide Product Offered
Table 84. Aurobindo Pharma Main Business
Table 85. Aurobindo Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Aurobindo Pharma Latest Developments
Table 87. Accord Healthcare Details, Company Type, Lacosamide Area Served and Its Competitors
Table 88. Accord Healthcare Lacosamide Product Offered
Table 89. Accord Healthcare Main Business
Table 90. Accord Healthcare Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Accord Healthcare Latest Developments
Table 92. Mylan Details, Company Type, Lacosamide Area Served and Its Competitors
Table 93. Mylan Lacosamide Product Offered
Table 94. Mylan Main Business
Table 95. Mylan Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Mylan Latest Developments
Table 97. Sun Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 98. Sun Pharma Lacosamide Product Offered
Table 99. Sun Pharma Main Business
Table 100. Sun Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Sun Pharma Latest Developments
Table 102. Apotex Details, Company Type, Lacosamide Area Served and Its Competitors
Table 103. Apotex Lacosamide Product Offered
Table 104. Apotex Lacosamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
List of Figures
Figure 1. Lacosamide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lacosamide Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Lacosamide Market Size Market Share by Type in 2021
Figure 7. Lacosamide in Adults
Figure 8. Global Lacosamide Market: Adults (2017-2022) & ($ Millions)
Figure 9. Lacosamide in Pediatric patients
Figure 10. Global Lacosamide Market: Pediatric patients (2017-2022) & ($ Millions)
Figure 11. Global Lacosamide Market Size Market Share by Application in 2021
Figure 12. Global Lacosamide Revenue Market Share by Player in 2021
Figure 13. Global Lacosamide Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Lacosamide Market Size 2017-2022 ($ Millions)
Figure 15. APAC Lacosamide Market Size 2017-2022 ($ Millions)
Figure 16. Europe Lacosamide Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Lacosamide Market Size 2017-2022 ($ Millions)
Figure 18. Americas Lacosamide Value Market Share by Country in 2021
Figure 19. Americas Lacosamide Consumption Market Share by Type in 2021
Figure 20. Americas Lacosamide Market Size Market Share by Application in 2021
Figure 21. United States Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Lacosamide Market Size Market Share by Region in 2021
Figure 26. APAC Lacosamide Market Size Market Share by Application in 2021
Figure 27. China Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Lacosamide Market Size Market Share by Country in 2021
Figure 34. Europe Lacosamide Market Size Market Share by Type in 2021
Figure 35. Europe Lacosamide Market Size Market Share by Application in 2021
Figure 36. Germany Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Lacosamide Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Lacosamide Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Lacosamide Market Size Market Share by Application in 2021
Figure 44. Egypt Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Lacosamide Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Lacosamide Market Size 2023-2028 ($ Millions)
Figure 50. APAC Lacosamide Market Size 2023-2028 ($ Millions)
Figure 51. Europe Lacosamide Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Lacosamide Market Size 2023-2028 ($ Millions)
Figure 53. United States Lacosamide Market Size 2023-2028 ($ Millions)
Figure 54. Canada Lacosamide Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Lacosamide Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Lacosamide Market Size 2023-2028 ($ Millions)
Figure 57. China Lacosamide Market Size 2023-2028 ($ Millions)
Figure 58. Japan Lacosamide Market Size 2023-2028 ($ Millions)
Figure 59. Korea Lacosamide Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Lacosamide Market Size 2023-2028 ($ Millions)
Figure 61. India Lacosamide Market Size 2023-2028 ($ Millions)
Figure 62. Australia Lacosamide Market Size 2023-2028 ($ Millions)
Figure 63. Germany Lacosamide Market Size 2023-2028 ($ Millions)
Figure 64. France Lacosamide Market Size 2023-2028 ($ Millions)
Figure 65. UK Lacosamide Market Size 2023-2028 ($ Millions)
Figure 66. Italy Lacosamide Market Size 2023-2028 ($ Millions)
Figure 67. Russia Lacosamide Market Size 2023-2028 ($ Millions)
Figure 68. Spain Lacosamide Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Lacosamide Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Lacosamide Market Size 2023-2028 ($ Millions)
Figure 71. Israel Lacosamide Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Lacosamide Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Lacosamide Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...